John Dahldorf

John Dahldorf

Direktor/Vorstandsmitglied bei HYPERFINE, INC.

Vermögen: 26 441 $ am 30.06.2026

69 Jahre
Health Technology
Distribution Services
Consumer Services

Profil

Mr. John T.
Dahldorf
is an Independent Director at Hyperfine, Inc. and a Chief Financial Officer at Q'Apel Medical, Inc. He is on the Board of Directors at Hyperfine, Inc. and Fyodor Biotechnologies, Inc. Mr. Dahldorf was previously employed as a Chief Financial Officer by Adagio Medical Holdings, Inc., a Chief Financial Officer by Adagio Medical, Inc., a Chief Financial Officer by Harmony Foods LLC, a Chief Financial Officer by Scn Bestco, a Chief Financial Officer by Benvenue Medical, Inc., a Chief Financial Officer by Acutus Medical, Inc., a Chief Financial Officer by Volcano Corp., a Co-Chief Executive Officer by Digirad Corp., a Finance Director by Arrow Electronics, Inc., and a Chief Finance Officer & General Manager by Volcano Therapeutics, Inc. He received his undergraduate degree from Western Illinois University and an MBA from Western Illinois University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
22.05.2026 19.586 ( 0,02 % ) 26 441 $ 30.06.2026

Aktive Positionen von John Dahldorf

UnternehmenPositionBeginn
HYPERFINE, INC. Direktor/Vorstandsmitglied 22.12.2021
Direktor/Vorstandsmitglied -
Finanzdirektor/CFO -

Ehemalige bekannte Positionen von John Dahldorf

UnternehmenPositionEnde
Finanzdirektor/CFO 01.03.2025
Finanzdirektor/CFO 01.03.2023
ACUTUS MEDICAL, INC. Finanzdirektor/CFO 01.01.2017
Sehen Sie sich die Erfahrung von John Dahldorf im Detail an

Ausbildung von John Dahldorf

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

54

Beziehungen ersten Grades

12

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen12

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. John Dahldorf